Pluripotent stem cells can self-renew indefinitely in culture while maintaining the ability to become almost any cell type in the human body. The derivation of induced pluripotent stem cells (iPSCs) from somatic cells has revolutionized the field of regenerative medicine. Patient-derived iPSCs serve as an invaluable reservoir of pluripotent cells, which researchers can differentiate into immune-compatible target cells and transplant to treat various genetic and degenerative diseases. iPSC derived cells also hold great promise for disease modeling in vitro and drug discovery. However, using iPSCs successfully depends on precise and reproducible reprogramming of somatic cells.
In this Technique Talk, Ritu Kumar will reveal how to optimize somatic cell reprogramming to reliably produce iPSCs for a wide range of applications.
How to derive iPSCs
The process of somatic cell reprogramming
Applications of iPSCs
Wednesday, May 11, 2022
2:30 – 3:30 PM Eastern Time
This webinar will also be available on-demand.
Ritu Kumar, PhD Director, Stem Cell Core Gladstone Institutes San Francisco, California
TS_WEBINARSIGNUP_TSU_Technique Talk: CRISPR for Genome Engineering in Drosophila December 14 2021
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com